Maybe someone can discover how the Mikaelian baby is progressing in negotiations with Farmatsevtik as he/she tours Uzbekistan, Kyrgyzstan, and Armenia on funds supplied by shareholders? I suppose the baby can't possibly deliver less revenues than Father and Son?